Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heron Therapeutics (HRTX) Change in Inventory (2016 - 2026)

Heron Therapeutics filings provide 11 years of Change in Inventory readings, the most recent being $169000.0 for Q1 2026.

  • On a quarterly basis, Change in Inventory fell 95.52% to $169000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $27.4 million, a 89.84% increase, with the full-year FY2025 number at $31.1 million, up 181.01% from a year prior.
  • Change in Inventory hit $169000.0 in Q1 2026 for Heron Therapeutics, down from $14.2 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $16.0 million in Q2 2025 to a low of -$9.1 million in Q3 2022.
  • Median Change in Inventory over the past 5 years was $391000.0 (2024), compared with a mean of $2.1 million.
  • Biggest five-year swings in Change in Inventory: crashed 599.46% in 2022 and later soared 6900.0% in 2024.
  • Heron Therapeutics' Change in Inventory stood at $2.3 million in 2022, then plummeted by 95.59% to $103000.0 in 2023, then soared by 6900.0% to $7.2 million in 2024, then soared by 96.77% to $14.2 million in 2025, then tumbled by 98.81% to $169000.0 in 2026.
  • The last three reported values for Change in Inventory were $169000.0 (Q1 2026), $14.2 million (Q4 2025), and -$2.9 million (Q3 2025) per Business Quant data.